Concepedia

Kenjiro Namikawa

KN

Statistics

Publications

56

Citations

2.1K

H-Index

26

Active since

2011

Affiliations

National Cancer Center(Current)

Saitama Medical University

Shizuoka Cancer Center

Niigata Cancer Center Hospital

Shinshu University

Kenjiro Namikawa is an author at National Cancer Center specializing in medicine, oncology, and melanoma immunotherapy.

Publications per year

2011–2024

56

Publications

56

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Yoshio Nakamura, Shigehisa Kitano, Akira Takahashi et al. · Oncotarget · 2016 · 160 citations · Full text

Medicine, Immunology, Oncology +17

Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients

Yasuhiro Nakamura, Kenjiro Namikawa, Kenji Yoshino et al. · Annals of Oncology · 2020 · 140 citations

Medicine, Clinical Sciences, Oncology +17

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa et al. · Cancer Medicine · 2019 · 112 citations · Full text

Medicine, Dermatology, Oncology +17

Characteristics of melanoma in Japan: a nationwide registry analysis 2011–2013

Taro Tomizuka, Kenjiro Namikawa, Takahiro Higashi · Melanoma Research · 2017 · 98 citations

Medicine, Dermatology, Oncology +15

Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

Kenjiro Namikawa, Yoshio Kiyohara, Tatsuya Takenouchi et al. · European Journal of Cancer · 2018 · 73 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–5 of 56